Ruthenium-containing SBA-12 catalysts for anisole hydrodeoxygenation

SBA-15- and SBA-16-Functionalized Silicas as New Carriers of Niacinamide

Amorphous silica as a food additive (E 551) is used in food materials (e.g., sweeteners, dairy products) for its anti-caking properties. The physicochemical properties of SiO2 also make it suitable to serve as a carrier of active substances in functional foods, dietary supplements, and drugs. Deficiency of niacinamide (vitamin B3, niacin) leads to several pathologies in the nervous system and causes one of the nutritional diseases called pellagra. The present study focuses on the use of hybrid ordered mesoporous silicas (SBA-15/SBA-16) functionalized with amino groups introduced through grafting or co-condensation with (N-vinylbenzyl)aminoethylaminopropyltrimethoxysilane (Z-6032) as novel carriers of niacinamide. They combine the characteristics of a relatively stable and chemically inert amorphous silica matrix with well-defined structural/textural parameters and organic functional groups that give specific chemical properties. The highest degree of carrier loading with niacinamide (16 wt.%) was recorded for the unmodified SBA-15. On the other hand, the highest degree of niacinamide release characterizes the functionalized SBA-15 sample (60% after 24 h), indicating that the presence of amino groups affects the release profile of niacinamide from the structure of the mesoporous silica.

Multifunctional mesoporous silica nanoparticles for biomedical applications

Mesoporous silica nanoparticles (MSNs) are recognized as a prime example of nanotechnology applied in the biomedical field, due to their easily tunable structure and composition, diverse surface functionalization properties, and excellent biocompatibility. Over the past two decades, researchers have developed a wide variety of MSNs-based nanoplatforms through careful design and controlled preparation techniques, demonstrating their adaptability to various biomedical application scenarios. With the continuous breakthroughs of MSNs in the fields of biosensing, disease diagnosis and treatment, tissue engineering, etc., MSNs are gradually moving from basic research to clinical trials. In this review, we provide a detailed summary of MSNs in the biomedical field, beginning with a comprehensive overview of their development history. We then discuss the types of MSNs-based nanostructured architectures, as well as the classification of MSNs-based nanocomposites according to the elements existed in various inorganic functional components. Subsequently, we summarize the primary purposes of surface-functionalized modifications of MSNs. In the following, we discuss the biomedical applications of MSNs, and highlight the MSNs-based targeted therapeutic modalities currently developed. Given the importance of clinical translation, we also summarize the progress of MSNs in clinical trials. Finally, we take a perspective on the future direction and remaining challenges of MSNs in the biomedical field.

Mesoporous Materials: Materials, Technological, and Environmental Applications

Research on the synthesis and characterization of ordered mesoporous materials with uniquely functionalized external and internal surfaces has intensified in the last decade [...].

High-Performance Na-CH3ONa/γ-Al2O3 Catalysts for High-Efficiency Conversion of Phenols to Ethers

An efficient alkaline catalyst with a porous structure (Na-CH₃ONa/γ-Al₂O₃) was prepared by the melting method. The wastewater from the semicoke plant (WW_SCP) was extracted multiple times with isometric dimethyl carbonate (DMC)-cyclohexane mixed solvent at room temperature to obtain an organic phase (OP) with a high concentration of phenols. Ether (OPCP) was obtained by catalytic conversion of OP over catalyst Na-CH₃ONa/γ-Al₂O₃ at 210 °C and with a reaction time of 2.5 h. Both OP and OPCP were analyzed with a gas chromatograph/mass spectrometer (GC/MS) and a quadrupole Exactive Orbitrap mass spectrometer (QPEOTMS). The results showed that only DMC, phenol, o-cresol, and other monohydric phenols were detected in OP, and only other saturated ethers such as anisole and O-methylanisole were detected in OPCP. Through the study of the catalytic conversion of the WW_SCP-related model compound, it was found that Na-CH₃ONa/γ-Al₂O₃ could effectively activate (deprotonate) phenol into phenate, and the strong nucleophilic oxyanion of phenate would attack the methyl carbon and carbonyl carbon on DMC to obtain methyl and methoxy groups. Thereby, phenate can be combined with methyl and methoxy groups to acquire the product anisole. In addition, the catalyst Na-CH₃ONa/γ-Al₂O₃ was found to still have high catalytic activity after 10 repeated cycles. It was speculated that this was related to the abundant microporous and mesoporous structure of the catalyst Na-CH₃ONa/γ-Al₂O₃.

Recent Advances in the Applications of Mesoporous Silica in Heterogenous Catalysis

Mesoporous silica is a class of silica material with a large specific surface area, high specific pore volume and meso-sized pores. These properties make mesoporous silica a good choice of...